Products
Platform
Research
Market
Learn
Alembic Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 1,917.06 | 1,717.22 | 1,783.83 | 1,702.24 | 1,664.72 |
| Other Income Qtr Cr | 6.91 | 6.50 | 14.19 | 9.50 | 16.74 |
| Operating Revenues Qtr | 1,910.15 | 1,710.72 | 1,769.64 | 1,692.74 | 1,647.98 |
Loading chart... | |||||
Operating Expenses Qtr | 1,594.46 | 1,429.37 | 1,497.71 | 1,432.52 | 1,408.71 |
Operating Profit Qtr | 315.69 | 281.35 | 271.93 | 260.22 | 239.27 |
EBITDA Qtr Cr | 322.60 | 287.85 | 286.12 | 269.72 | 268.88 |
Depreciation Qtr | 76.07 | 73.77 | 68.99 | 70.04 | 70.51 |
Net Profit Qtr | 184.71 | 154.38 | 156.89 | 138.42 | 153.40 |
Basic EPS Qtr | 9.40 | 7.85 | 7.98 | 7.01 | 7.79 |
Open Demat Account
Open Demat Account